We are redirecting you to the source. If you are not redirected in 3 seconds, please click here.

VP, Global Rare Disease Franchise at REGENXBIOSince our founding in 2009, REGENXBIO has pioneered what’s possible in gene therapy. Today, we are advancing a pipeline of gene therapies designed to improve the lives of patients facing serious rare and retinal diseases and preparing to bring innovative new medicines to patients.. Company Location: Remote.